Influence of metabolic and proinflammatory factors on diastolic heart failure formation in females with essential hypertension

Cover Page

Cite item

Full Text

Abstract

Relevance. Diastolic chronic heart failure (CHF) is a characteristic complication of essential hypertension (EH).

Materials and methods. 62 females with EH were examined. The first group (n=47, mean age 51.5±6.2 years) – persons with EH complicated by diastolic CHF, the second group (n=15, 49.8±6.7 years) – persons with uncomplicated EH. The diagnosis of CHF in females of the first group is confirmed by the data of the test with 6-minute walking, increased blood content of the N-terminal precursor of the brain natriuretic peptide, the presence of left atrial dilatation, hypertrophy and disturbed left ventricle (LV) relaxation. The levels of indices of lipid, carbohydrate, purine metabolism, mediators of systemic inflammation (С-reactive protein), tumor necrosis factor alpha (TNF-a), interleukin-6 (IL-6) were studied and a correlation analysis of the whole set of laboratory data with 6-minute walking test results and an integral index of diastolic LV dysfunction (E/e’).

Results. Females with EH complicated initial manifestations of diastolic heart failure, characterized by significantly higher, but the corresponding values of the reference range, the content in blood TNF-a, IL-6 compared with females with uncomplicated EH. In females with hypertension complicated initial manifestations of diastolic heart failure is established significant correlation between blood levels of atherogenic lipids and lipoproteins, glucose, uric acid, CRP, TNF-a, IL-6 on the one hand and indices characterizing reduced tolerance to physical load, diastolic LV dysfunction.

Conclusion. Formation of diastolic heart failure clinical syndrome as well as disturbances of LV relax function in hypertensive females allows participation of metabolic factors and pro-inflammatory pattern.

About the authors

Anton V. Barsukov

Kirov Military Medical Academy

Author for correspondence.
Email: avbarsukov@yandex.ru
ORCID iD: 0000-0002-1943-9545

D. Sci. (Med.), Prof., Kirov Military Medical Academy

Russian Federation, Saint Petersburg

Alla Yu. Seidova

Health Unit of Internal Ministry of the Russian Federation in Saint Petersburg and Leningrad region

Email: allo4ka1989@bk.ru
ORCID iD: 0000-0001-8333-2550

Cand. Sci. (Med.), Health Unit of Internal Ministry of the Russian Federation in Saint Petersburg and Leningrad region

Russian Federation, Saint Petersburg

Ksenia A. Shcherbakova

Kirov Military Medical Academy

Email: ksu2204@yandex.ru
ORCID iD: 0000-0001-8555-5192

cardiologist, Kirov Military Medical Academy

Russian Federation, Saint Petersburg

References

  1. Parikh KS, Sharma K, Fiuzat M et al. Heart Failure With Preserved Ejection Fraction Expert Panel Report. J Am Coll Cardiol HF 2018; 6 (8): 619–32. doi: 10.1016/j.jchf.2018.06.008
  2. Guo L, Guo X, Chang Y et al. Prevalence and risk factors of heart failure with preserved ejection fraction: A population-based study in Northeast China. Int J Environ Res Public Health 2016; 13: 770. doi: 10.3390/ijerph13080770
  3. Shirazi LF, Bissett J, Romeo F, Mehta JL. Role of inflammation in heart failure. Curr Ather Rep 2017; 19: 27. doi: 10.1007/s11883-017-0660-3
  4. Никифоров В.С., Никищенкова Ю.В. Структурно-функциональные изменения миокарда и клапанов сердца у больных коронарной патологией старших возрастных групп. Мед. совет. 2018; 5: 122–6. [Nikiforov V.S., Nikishchenkova Iu.V. Strukturno-funktsional’nye izmeneniia miokarda i klapanov serdtsa u bol’nykh koronarnoi patologiei starshikh vozrastnykh grupp. Med. sovet. 2018; 5: 122–6 (in Russian).]
  5. Kosmala W, Rojek A, Przewlocka-Kosmala M. Contributions of nondiastolic factors to exercise intolerance in heart failure with preserved ejection fraction. J Am Coll Cardiol 2016; 67: 659–70. doi: 10.1016/j.jacc.2015.10.096
  6. Huang W, Chai SC, Lee SGS. Prognostic Factors After Index Hospitalization for Heart Failure With Preserved Ejection Fraction. Am J Cardiol 2017; 119: 2017–20. doi: 10.1016/j.amjcard.2017.03.032
  7. Чазова И.Е., Жернакова Ю.В. от имени экспертов. Клинические рекомендации. Диагностика и лечение артериальной гипертонии. Системные гипертензии. 2019; 16 (1): 6–31. doi: 10.26442/2075082X.2019.1.190179 [Chazova I.E., Zhernakova Yu.V. on behalf of the experts. Clinical guidelines. Diagnosis and treatment of arterial hypertension. Systemic Hypertension. 2019; 16 (1): 6–31. doi: 10.26442/2075082X.2019.1.190179 (in Russian).]
  8. Agabiti E, France MA, Uk AD et al. ESC/ESH Guidelines for the management of arterial hypertension The Task Force for the management of arterial hypertension of the European Society of Cardiology (ESC) and the European Society of Hypertension. Eur Heart J 2018; 39 (33): 3021–104. doi: 10.1097/HJH.0000000000001940
  9. Мареев В.Ю., Фомин И.В., Агеев Ф.Т. и др. Клинические рекомендации. Хроническая сердечная недостаточность (ХСН). Журн. Сердечная Недостаточность. 2017; 18 (1): 3–40. doi: 10.18087/rhfj.2017.1.2346 [Mareev V.Iu., Fomin I.V., Ageev F.T. et al. Klinicheskie rekomendatsii. Khronicheskaia serdechnaia nedostatochnost’ (KhSN). Zhurn. Serdechnaia Nedostatochnost’. 2017; 18 (1): 3–40. doi: 10.18087/rhfj.2017.1.2346 (in Russian).]
  10. Ponikowski P, Voors AA, Anker SD et al. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur J Heart Fail 2016; 18 (8): 883–1084. doi: 10.1093/eurheartj/ehw128
  11. Nagueh SF, Smiseth OA, Appleton CP et al. Recommendations for the Evaluation of Left Ventricular Diastolic Function by Echocardiography: An Update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr 2016; 29: 277–314. doi: 10.1016/j.echo.2016.01.011
  12. Lang RM, Badano LP, Mor-Avi V et al. Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American society of echocardiography (ASE) and the European association of cardiovascular imaging (EASI) Wallace. J Am Soc Echocardiogr 2015; 28 (1): 1–39. doi: 10.1016/j.echo.2014.10.003
  13. Ежов М.В., Сергиенко И.В., Кухарчук В.В. и др. Диагностика и коррекция нарушений липидного обмена с целью профилактики и лечения атеросклероза: Российские рекомендации (VI пересмотр). Атеросклероз и дислипидемии. 2017; 3: 5–22. [Ezhov M.V., Sergienko I.V., Kukharchuk V.V. et al. Diagnostika i korrektsiia narushenii lipidnogo obmena s tsel’iu profilaktiki i lecheniia ateroskleroza: Rossiiskie rekomendatsii (VI peresmotr). Ateroskleroz i dislipidemii. 2017; 3: 5–22 (in Russian).]
  14. Roger VL, Go AS, Lloyd-Jones DM et al. A report from the American Heart Association. Circulation 2011; 123: e18–e209. doi: 10.1161/CIR.0b013e3182009701
  15. Eaton CB, Pettinger M, Rossouw J et al. Risk Factors for Incident Hospitalized Heart Failure with Preserved Versus Reduced Ejection Fraction in a Multiracial Cohort of Postmenopausal Women. Circulation: Heart Failure 2016; 9 (10): e002883. doi: 10.1161/CIRCHEARTFAILURE.115.002883
  16. Wohlfahrt P, Redfield MM, Lopez-Jimenez F et al. Impact of general and central adiposity on ventricular-arterial aging in women and men. J Am Coll Cardiol HF 2014; 2: 489–99. doi: 10.1016/j.jchf.2014.03.014
  17. Gomberg-Maitland M, Shah SJ, Guazzi M. Inflammation in heart failure with preserved ejection fraction. J Am Coll Cardiol HF 2016; 4 (4): 325–8. doi: 10.1016/j.jchf.2015.11.013
  18. Барсуков А.В., Сеидова А.Ю., Гордиенко А.В. и др. Гипертоническая болезнь и хроническая сердечная недостаточность с сохраненной сократительной способностью левого желудочка: фокус на гендерспецифические особенности провоспалительного статуса. Артериальная гипертензия. 2017; 23 (5): 457–67. doi: 10.18705/1607-419X-2016-22-5-457-467 [Barsukov A.V., Seidova A.Iu., Gordienko A.V. et al. Gipertonicheskaia bolezn’ i khronicheskaia serdechnaia nedostatochnost’ s sokhranennoi sokratitel’noi sposobnost’iu levogo zheludochka: fokus na genderspetsificheskie osobennosti provospalitel’nogo statusa. Arterial’naia gipertenziia. 2017; 23 (5): 457–67. doi: 10.18705/1607-419X-2016-22-5-457-467 (in Russian).]
  19. Свеклина Т.С., Таланцева М.С., Барсуков А.В. Метаболический синдром и воспаление. Клин. лабораторная диагностика. 2013; 3: 7–10. [Sveklina T.S., Talantseva M.S., Barsukov A.V. Metabolicheskii sindrom i vospalenie. Klin. laboratornaia diagnostika. 2013; 3: 7–10 (in Russian).]
  20. Wu CK, Huang YT, Lin HH et al. Dissecting the mechanisms of left ventricular diastolic dysfunction and inflammation in peritoneal dialysis patients. PLoS ONE 2013; 8 (5): e62722. doi: 10.1371/journal.pone.0062722

Supplementary files

Supplementary Files
Action
1. JATS XML
Download
2. Fig. 1. Dependence of the result of HSH on the serum values of mediators of systemic inflammation in women with hypertension complicated by the initial manifestations of SDS.

Download (166KB)
Indexing metadata

Copyright (c) 2020 Eco-Vector

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies